Nanomedicine from cancer to COVID19 UCL Medical Sciences Lecture

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=nQuhYYweQ2E

A recording of a live talk and Q A with UCL's Gavin Jell, Associate Professor in Nanotechnology and Regenerative Medicine, on Nanomedicine: from cancer to COVID-19. • This talk explored what nanomedicine is, the advantages nanotechnologies offer in the treatment and diagnosis of disease, and future challenges. • Nanotechnology in medicine could involve employing nanoparticles to deliver drugs, heat, light or other substances to specific types of cells (such as cancer cells). This technique reduces damage to healthy cells in the body and allows for earlier detection of disease. • Dr Jell’s research group is interested in understanding the nanoparticle (particle of matter that is between 1 and 100 nanometres in diameter) and biological interactions that occur when they are injected into the body, and how to direct these interactions so they get to the sites where we want them (and avoid accumulation at sites we don’t). • As well as his role in UCL as an associate professor, he is also a trustee for the British Society of Nanomedicine and the Course Director for the BSc/MSci in Medical Innovation Enterprise (https://www.ucl.ac.uk/prospective-stu..., and the MSc in Nanotechnology Regenerative Medicine. • Find out more about studying at UCL Faculty of Medical Sciences: https://www.ucl.ac.uk/medical-science...

#############################

New on site